Last reviewed · How we verify
Placebo of Gasmotin
Placebo of Gasmotin is a Small molecule drug developed by Daewoong Pharmaceutical Co. LTD.. It is currently in Phase 3 development for Control arm in clinical trials for Gasmotin (active ingredient: mosapride or similar prokinetic agent).
This is a placebo formulation with no active pharmacological mechanism.
This is a placebo formulation with no active pharmacological mechanism. Used for Control arm in clinical trials for Gasmotin (active ingredient: mosapride or similar prokinetic agent).
At a glance
| Generic name | Placebo of Gasmotin |
|---|---|
| Sponsor | Daewoong Pharmaceutical Co. LTD. |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | Phase 3 |
Mechanism of action
As a placebo of Gasmotin, this product contains no active ingredient and produces no direct pharmacological effect. It is used as a control in clinical trials to assess the efficacy of the active Gasmotin formulation through comparison of outcomes between treatment and placebo groups.
Approved indications
- Control arm in clinical trials for Gasmotin (active ingredient: mosapride or similar prokinetic agent)
Common side effects
Key clinical trials
- The Effect of Two Prokinetics in Patients With Functional Dyspepsia (NA)
- Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PHASE3)
- Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2) (PHASE3)
- The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones (PHASE4)
- Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia (PHASE3)
- Effect of Proton Pump Inhibitor and Mosapride on Acid Pocket in Gastroesophageal Reflux Disease (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of Gasmotin CI brief — competitive landscape report
- Placebo of Gasmotin updates RSS · CI watch RSS
- Daewoong Pharmaceutical Co. LTD. portfolio CI
Frequently asked questions about Placebo of Gasmotin
What is Placebo of Gasmotin?
How does Placebo of Gasmotin work?
What is Placebo of Gasmotin used for?
Who makes Placebo of Gasmotin?
What development phase is Placebo of Gasmotin in?
Related
- Manufacturer: Daewoong Pharmaceutical Co. LTD. — full pipeline
- Therapeutic area: All drugs in Gastroenterology
- Indication: Drugs for Control arm in clinical trials for Gasmotin (active ingredient: mosapride or similar prokinetic agent)
- Compare: Placebo of Gasmotin vs similar drugs
- Pricing: Placebo of Gasmotin cost, discount & access